Rosetta Genomics Ltd. Proceeds from Convertible Debt
Rosetta Genomics Ltd. reported Proceeds from Convertible Debt of $1.75 million for the 12-month period ending 2012-12-31, per its 20-F filed 2015-03-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2015-03-16
| Period end | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 12 month |
|---|---|---|
| 2012-12-31 | $1.75M 20-F · filed 2015-03-16 | |
| 2012-06-30 | $1.75M 6-K · filed 2013-09-09 | |
| 2011-12-31 | $0.00 6-K · filed 2012-12-07 | |
| 2010-12-31 | $0.00 6-K · filed 2012-12-07 | |
| 2009-12-31 | $750.00K 6-K · filed 2012-12-07 |